Abstract
Background
Pulmonary hypertension is common in chronic kidney disease (CKD) patients. However, the prognostic value of pulmonary hypertension in Chinese predialytic CKD patients is rarely reported. We evaluated the relevant factors and prognostic value of pulmonary hypertension in CKD patients.
Methods
This retrospective cohort study enrolled 1092 predialytic patients from The Third Affiliated Hospital of Sun Yat-Sen University from May 1st, 2011, to December 31st, 2016. Data of interest were retrieved from electronic medical records. Pulmonary hypertension was defined as pulmonary arterial systolic pressure (PASP) ≥ 35 mmHg by echocardiology. All participants were followed from the date of the first echocardiography examination. The primary endpoints were all-cause mortality and cardiovascular mortality. The secondary endpoint was end-stage renal disease (ESRD) defined as starting renal replacement therapy.
Results
The prevalence of pulmonary hypertension was 15.9% in the study population. For CKD stage 1, 2, 3a, 3b, 4 and 5, the prevalence was 6.0%, 9.6%, 17.2%, 13.3%, 20.7% and 26.6%, respectively. Older age, lower left ventricular ejection fraction, anemia and higher pulse pressure were independently associated with pulmonary hypertension in CKD patients. In multivariate Cox regression analysis, pulmonary hypertension was the independent risk factor for cardiovascular mortality, but not of all-cause mortality and ESRD.
Conclusions
Pulmonary hypertension is not rare in early CKD patients. Patients with older age, anemia, higher pulse pressure and compromised heart function were more likely to comorbid pulmonary hypertension. Pulmonary hypertension maybe a sign of worse cardiovascular outcome in CKD patients.
Similar content being viewed by others
References
National Institutes Of Health (2016) United States Renal Data System. 2016 USRDS annual data report: epidemiology of kidney disease in the United States
Zhang L et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. The Lancet 379:815–822. https://doi.org/10.1016/S0140-6736(12)60033-6
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305. https://doi.org/10.1056/NEJMoa041031
He Y, Wang Y, Luo X, Ke J, Du Y, Li M (2015) Risk factors for pulmonary hypertension in maintenance hemodialysis patients: a cross-sectional study. Int Urol Nephrol 47:1889–1897. https://doi.org/10.1007/s11255-015-1119-5
Li Z et al (2014) Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients. Int Urol Nephrol 46:141–149. https://doi.org/10.1007/s11255-013-0486-z
Agarwal R (2012) Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol Dial Transpl 27:3908–3914. https://doi.org/10.1093/ndt/gfr661
Zeng Y et al (2016) Risk factors for pulmonary hypertension in patients receiving maintenance peritoneal dialysis. Braz J Med Biol Res 49:e4733. https://doi.org/10.1590/1414-431X20154733
Zhang L et al (2016) Prevalence and risk factors for pulmonary arterial hypertension in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis. Ren Fail 38:815–821. https://doi.org/10.3109/0886022X.2015.1103637
Xu Q et al (2015) Association of pulmonary hypertension with mortality in incident peritoneal dialysis patients. Perit Dial Int 35:537–544. https://doi.org/10.3747/pdi.2013.00332
Unal A et al (2009) Pulmonary hypertension in peritoneal dialysis patients: prevalence and risk factors. Perit Dial Int 29:191–198
Navaneethan SD et al (2016) Prevalence, predictors, and outcomes of pulmonary hypertension in CKD. J Am Soc Nephrol 27:877–886. https://doi.org/10.1681/ASN.2014111111
Shang W, Li Y, Ren Y, Li W, Wei H, Dong J (2018) Prevalence of pulmonary hypertension in patients with chronic kidney disease without dialysis: a meta-analysis. Int Urol Nephrol 50:1497–1504. https://doi.org/10.1007/s11255-018-1853-6
Tang M, Batty JA, Lin C, Fan X, Chan KE, Kalim S (2018) Pulmonary hypertension, mortality, and cardiovascular disease in CKD and ESRD patients: a systematic review and meta-analysis. Am J Kidney Dis 72:75–83. https://doi.org/10.1053/j.ajkd.2017.11.018
Simonneau G et al (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62:D34–D41. https://doi.org/10.1016/j.jacc.2013.10.029
KDIGO 2012 (2013) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney disease: improving global outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. 3:1–150
Matsushita K et al (2012) Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 307:1941–1951. https://doi.org/10.1001/jama.2012.3954
Levey AS et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
Lang RM et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463. https://doi.org/10.1016/j.echo.2005.10.005
Li Z et al (2014) Pulmonary hypertension: epidemiology in different CKD stages and its association with cardiovascular morbidity. PLoS ONE 9:e114392. https://doi.org/10.1371/journal.pone.0114392
Kinoshita T, Tawa M, Suzuki T, Aimi Y, Asai T, Okamura T (2017) Endothelial dysfunction of internal thoracic artery graft in patients with chronic kidney disease. J Thorac Cardiovasc Surg 153:317–324. https://doi.org/10.1016/j.jtcvs.2016.09.037
Kim SC, Chang HJ, Kim MG, Jo SK, Cho WY, Kim HK (2015) Relationship between pulmonary hypertension, peripheral vascular calcification, and major cardiovascular events in dialysis patients. Kidney Res Clin Pract 34:28–34. https://doi.org/10.1016/j.krcp.2015.01.003
Bolignano D et al (2013) Pulmonary hypertension in CKD. Am J Kidney Dis 61:612–622. https://doi.org/10.1053/j.ajkd.2012.07.029
Forhecz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohaszka Z, Janoskuti L (2009) Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 158:659–666. https://doi.org/10.1016/j.ahj.2009.07.024
Shah N, Pahuja M, Pant S, Handa A, Agarwal V, Patel N, Dusaj R (2017) Red cell distribution width and risk of cardiovascular mortality: Insights from National Health and Nutrition Examination Survey (NHANES)-III. Int J Cardiol 232:105–110. https://doi.org/10.1016/j.ijcard.2017.01.045
Rhodes CJ, Wharton J, Howard LS, Gibbs JSR, Wilkins MR (2011) Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart 97:1054–1060. https://doi.org/10.1136/hrt.2011.224857
Felker GM et al (2007) Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50:40–47. https://doi.org/10.1016/j.jacc.2007.02.067
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Human or animal rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethics committee of The Third Affiliated Hospital of Sun Yat-sen University and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
The ethics committee approved that informed consent could be waived due to retrospective study design.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zhang, X., Zhao, W., Ma, X. et al. Prognostic value of pulmonary hypertension in pre-dialysis chronic kidney disease patients. Int Urol Nephrol 52, 2329–2336 (2020). https://doi.org/10.1007/s11255-020-02589-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-020-02589-6